Coinfections with hepatitis G and/or C virus in hepatitis B-related chronic liver disease

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 30, Issue 4, 1999, Pages 741-749

  Pramoolsinsap, Chutima ^a,b   Sirikalchayanonta, Vorachai ^b   Busakorn, Wanta ^a   Poovorawan, Yong ^a   Hirsch, Petra ^a   Theamboonlers, Apiradee ^a   Lerdverasirikul, Pravit ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADULT; ARTICLE; CASE CONTROL STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; MIDDLE AGED; PREVALENCE; SUPERINFECTION; THAILAND; TREATMENT OUTCOME; VIROLOGY; VIRUS HEPATITIS;

ADULT; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; INTERFERON-ALPHA; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; SUPERINFECTION; THAILAND; TREATMENT OUTCOME;

EID: 0033290721     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Alter MJ, Gallagher M, Morris TT. et al. Acute non A-E hepatitis in the United States and the role of hepatitis G infection. Sentinel Countries Viral Hepatitis Study Team. N Engl J Med 1997; 336: 741-6.
2. Beasley RP. Hepatitis B virus:The major etiology of hepatocellular carcinoma. Cancer 1988; 61: 1942-56.
3. Benvegnu L, Fattovitch G, Noventa F. et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. Cancer 1994, 74: 2442-8.
4. Chert DS, Kuo GS, Sung JL. et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease:The Taiwan experience. J Infect Dis 1990; 162: 817-22.
5. Chu CM, Sheen JS, Liaw YF. The role of hepatitis C virus in fulminant viral hepatitis in an endemic area of hepatitis A and B. Gastroenterology 1994; 107: 189-9.
6. Colombari R, Dhillon AP, Piazzola E, et al. Chronic hepatitis in multiple virus infection:histopathological evaluation. Histopathology 1993; 22: 319-25.
7. Colombo M, Kuo G, Choo QL, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2: 1006-8.
8. Crespo J, Lozano JL, de la Cruz F, et al. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am J Gastroenterol 1994; 89: 1147-51.
9. Diamentis I, Bassetti S, Erb P, et al. High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts. J Hepatol 1997; 26: 794-7.
10. Fattovitch G, Tagger A, Brollo L, et al. Hepatitis C virus infection in chronic hepatitis B virus carriers. J Infect Dis 1991; 163: 400-2.
11. Fong TL, Di Biceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patient with chronic hepatitis B. Hepatology 1991; 14: 64-7.
12. Francesconi R, Giostra F, Ballardini G, et al. Clinical implications of GBV-C/HGV infection in patients with "HCV-related chronic hepatitis. J Hepatol 1997; 26: 1165-72.
13. Hino O, Kajino K. Hepatitis virus-related hepatocarcinogenesis. Intervirology 1994; 37: 133-5.
14. Kao JH, Chen PJ, Lai MY, Chen W, Chen DS. Effects of GB virus-C/hepatitis G virus on hepatitis B and C viremia in multiple hepatitis virus infections. Arch Virol 1998; 143: 797-802.
15. Knodell RG, Ishak KG, Black WC. et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
16. Lau GK, Wu PC, Lo CK, Lau V, Lam SK. Histological changes of concurrent hepatitis C virus infection in asymptomatic hepatitis B virus patients. J Gastroenterol Hepatol 1998; 13: 52-6.
17. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-45.
18. Liaw YF, Tsai JJ, Sheen IS, Chien RN, Lin DY, Chu CM. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology 1994; 106: 1048-53.
19. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995; 22: 1101-8.
20. Linnen J, Wages JJr, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus:a transfusion-transmissible agent. Science 1996; 271: 505-8.
21. Ohkawa K, Hayashi N, Yuki N, et al. Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients. J Hepatol 1994; 21: 509-14.
22. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers:application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673-9.
23. Popper H, Shafritz DA, Hoofnagle JH. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology 1987; 7: 764-72.
24. Pramoolsinsap C. Hepatitis G virus. Med Prog 1998; 25: 23-8.
25. Pramoolsinsap C, Poovorawan Y, Sura T, Theamboonlers A, Busagorn N, Kurathong S. Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease. Southeast Asian J Trop Med Public Health 1998; 29: 480-9.
26. Saito I, Miyamura T, Ohyabashi A, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6547-9.
27. Sato S, Shigetoshi F, Tanaka M, et al. Co-infection of the hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 1994; 21: 159-66.
28. Sheen IS, Liaw YF, Chu CM, Pao CC. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection. J Infect Dis 1992; 165: 831-4.
29. Shih CM, Lo SJ, Miyamura T, Chcn SY, Lee YH. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993; 67: 5823-32.
30. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 564-9.
31. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-6.
32. Tsai SL, Liaw YF, Yeh CT, Chu CM, Kuo GC. Cellular immune responses in hepatitis C virus. Hepatology 1995; 21: 908-12.
33. Villari D, Pernice M, Spinella S, et al. Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections:a histological study. Am J Gastroenterol 1995; 90: 955-8.
34. Wang JT, Tsai FC, Lee CZ, et al. A prospective study of transfusion-transmitted GB virus C infection:similar frequency but different clinical presentation compared with hepatitis C virus. Blood 1996; 88: 1881-6.
35. Wu JC, Chen CL, Hou MC, Chen TZ, Lee SD, Lo KJ. Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitation of the polymerase chain reaction. Hepatology 1994; 19: 836-40.